VYNE Therapeutics: Q2 Earnings Insights

VYNE Therapeutics VYNE reported its Q2 earnings results on Friday, August 12, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

VYNE Therapeutics beat estimated earnings by 23.53%, reporting an EPS of $-0.13 versus an estimate of $-0.17.

Revenue was down $4.13 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.26 which was followed by a 7.25% increase in the share price the next day.

Here's a look at VYNE Therapeutics's past performance:

To track all earnings releases for VYNE Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.